메뉴 건너뛰기




Volumn 11, Issue 21, 2005, Pages 7886-7890

Oncolytic herpes simplex virus vector G47Δ in combination with androgen ablation for the treatment of human prostate adenocarcinoma

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; FLUTAMIDE; GENE PRODUCT; GONADORELIN DERIVATIVE; HERPESVIRUS VECTOR; PROTEIN G47DELTA; UNCLASSIFIED DRUG;

EID: 27744547095     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-1090     Document Type: Article
Times cited : (49)

References (21)
  • 1
    • 0034036536 scopus 로고    scopus 로고
    • Conditionally replicating herpes vectors for cancer therapy
    • Martuza RL. Conditionally replicating herpes vectors for cancer therapy. J Clin Invest 2000;105:841-6.
    • (2000) J Clin Invest , vol.105 , pp. 841-846
    • Martuza, R.L.1
  • 2
    • 0029023868 scopus 로고
    • Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas
    • Mineta T, Rabkin SD, Yazaki T, Hunter WD, Martuza RL. Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nat Med 1995;1:938-43.
    • (1995) Nat Med , vol.1 , pp. 938-943
    • Mineta, T.1    Rabkin, S.D.2    Yazaki, T.3    Hunter, W.D.4    Martuza, R.L.5
  • 3
    • 12944315014 scopus 로고    scopus 로고
    • Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: Results of a phase I trial
    • Markert JM, Medlock MD, Rabkin SD, et al. Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial. Gene Ther 2000;7:867-74.
    • (2000) Gene Ther , vol.7 , pp. 867-874
    • Markert, J.M.1    Medlock, M.D.2    Rabkin, S.D.3
  • 4
    • 0033199929 scopus 로고    scopus 로고
    • Local and systemic therapy of human prostate adenocarcinoma with the conditionally replicating herpes simplex virus vector G207
    • Walker JR, McGeagh KG, Sundaresan P, Jorgensen TJ, Rabkin SD, Martuza RL. Local and systemic therapy of human prostate adenocarcinoma with the conditionally replicating herpes simplex virus vector G207. Hum Gene Ther 1999;10:2237-43.
    • (1999) Hum Gene Ther , vol.10 , pp. 2237-2243
    • Walker, J.R.1    McGeagh, K.G.2    Sundaresan, P.3    Jorgensen, T.J.4    Rabkin, S.D.5    Martuza, R.L.6
  • 5
    • 0034922940 scopus 로고    scopus 로고
    • Preclinical safety evaluation of G207, a replication-competent herpes simplex virus type 1, inoculated intraprostatically in mice and nonhuman primates
    • Varghese S, Newsome JT, Rabkin SD, et al. Preclinical safety evaluation of G207, a replication-competent herpes simplex virus type 1, inoculated intraprostatically in mice and nonhuman primates. Hum Gene Ther 2001;12:999-1010.
    • (2001) Hum Gene Ther , vol.12 , pp. 999-1010
    • Varghese, S.1    Newsome, J.T.2    Rabkin, S.D.3
  • 6
    • 0035933088 scopus 로고    scopus 로고
    • Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing
    • Todo T, Martuza RL, Rabkin SD, Johnson PA. Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing. Proc Natl Acad Sci U S A 2001;98:6396-401.
    • (2001) Proc Natl Acad Sci U S A , vol.98 , pp. 6396-6401
    • Todo, T.1    Martuza, R.L.2    Rabkin, S.D.3    Johnson, P.A.4
  • 7
    • 0030860498 scopus 로고    scopus 로고
    • Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model
    • Foster BA, Gingrich JR, Kwon ED, Madias C, Greenberg NM. Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model. Cancer Res 1997;57:3325-30.
    • (1997) Cancer Res , vol.57 , pp. 3325-3330
    • Foster, B.A.1    Gingrich, J.R.2    Kwon, E.D.3    Madias, C.4    Greenberg, N.M.5
  • 8
    • 0034780803 scopus 로고    scopus 로고
    • Ionizing radiation does not alter the antitumor activity of herpes simplex virus vector G207 in subcutaneous tumor models of human and murine prostate cancer
    • Jorgensen TJ, Katz S, Wittmack EK, et al. Ionizing radiation does not alter the antitumor activity of herpes simplex virus vector G207 in subcutaneous tumor models of human and murine prostate cancer. Neoplasia 2001;3:451-6.
    • (2001) Neoplasia , vol.3 , pp. 451-456
    • Jorgensen, T.J.1    Katz, S.2    Wittmack, E.K.3
  • 9
    • 0021182422 scopus 로고
    • A new serially transplantable human prostatic cancer (HONDA) in nude mice
    • Ito YZ, Nakazato Y. A new serially transplantable human prostatic cancer (HONDA) in nude mice. J Urol 1984;132:384-7.
    • (1984) J Urol , vol.132 , pp. 384-387
    • Ito, Y.Z.1    Nakazato, Y.2
  • 10
    • 0022408573 scopus 로고
    • Hormone dependency of a serially transplantable human prostatic cancer (HONDA) in nude mice
    • Ito YZ, Mashimo S, Nakazato Y, Takikawa H. Hormone dependency of a serially transplantable human prostatic cancer (HONDA) in nude mice. Cancer Res 1985;45:5058-63.
    • (1985) Cancer Res , vol.45 , pp. 5058-5063
    • Ito, Y.Z.1    Mashimo, S.2    Nakazato, Y.3    Takikawa, H.4
  • 11
    • 0033589694 scopus 로고    scopus 로고
    • Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus
    • Todo T, Rabkin SD, Sundaresan P, et al. Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus. Hum Gene Ther 1999;10:2741-55.
    • (1999) Hum Gene Ther , vol.10 , pp. 2741-2755
    • Todo, T.1    Rabkin, S.D.2    Sundaresan, P.3
  • 12
    • 0035138174 scopus 로고    scopus 로고
    • In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity
    • Todo T, Martuza RL, Dallman MJ, Rabkin SD. In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity. Cancer Res 2001;61:153-61.
    • (2001) Cancer Res , vol.61 , pp. 153-161
    • Todo, T.1    Martuza, R.L.2    Dallman, M.J.3    Rabkin, S.D.4
  • 13
    • 0029924404 scopus 로고    scopus 로고
    • Prostate cancer gene therapy, herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models
    • Eastham JA, Chen SH, Sehgal I, et al. Prostate cancer gene therapy, herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models. Hum Gene Ther 1996;7:515-23.
    • (1996) Hum Gene Ther , vol.7 , pp. 515-523
    • Eastham, J.A.1    Chen, S.H.2    Sehgal, I.3
  • 14
    • 0033869485 scopus 로고    scopus 로고
    • Efficacious chemoprevention of primary prostate cancer by flutamide in an autochthonous transgenic model
    • Raghow S, Kuliyev E, Steakley M, Greenberg N, Steiner MS. Efficacious chemoprevention of primary prostate cancer by flutamide in an autochthonous transgenic model. Cancer Res 2000;60:4093-7.
    • (2000) Cancer Res , vol.60 , pp. 4093-4097
    • Raghow, S.1    Kuliyev, E.2    Steakley, M.3    Greenberg, N.4    Steiner, M.S.5
  • 15
    • 0029841340 scopus 로고    scopus 로고
    • A herpesvirus genetic element which affects translation in the absence of the viral GADD34 function
    • Mohr I, Gluzman Y. A herpesvirus genetic element which affects translation in the absence of the viral GADD34 function. EMBO J 1996;15:4759-66.
    • (1996) EMBO J , vol.15 , pp. 4759-4766
    • Mohr, I.1    Gluzman, Y.2
  • 16
    • 85080780957 scopus 로고
    • Antitumor activity of a nonsteroidal antiandrogenic drug, flutamide against prostatic tumors
    • Kuroiwa S, Shibasaki C, Iizuka E, Ekimoto H, Ito YZ. Antitumor activity of a nonsteroidal antiandrogenic drug, flutamide against prostatic tumors. Kiso to Rinsho 1995;29:887-97.
    • (1995) Kiso to Rinsho , vol.29 , pp. 887-897
    • Kuroiwa, S.1    Shibasaki, C.2    Iizuka, E.3    Ekimoto, H.4    Ito, Y.Z.5
  • 17
    • 0034897683 scopus 로고    scopus 로고
    • Antiandrogen monotherapy: A new form of treatment for patients with prostate cancer
    • Kolvenbag GJ, Iversen P, Newling DW. Antiandrogen monotherapy: a new form of treatment for patients with prostate cancer. Urology 2001;58:16-23.
    • (2001) Urology , vol.58 , pp. 16-23
    • Kolvenbag, G.J.1    Iversen, P.2    Newling, D.W.3
  • 18
    • 0034728828 scopus 로고    scopus 로고
    • Maximum androgen blockade in advanced prostate cancer: An overview of the randomised trials
    • Group PCTC. Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials. Lancet 2000;355:1491-8.
    • (2000) Lancet , vol.355 , pp. 1491-1498
  • 19
    • 0025971676 scopus 로고
    • Advanced prostatic carcinoma. Early versus late endocrine therapy
    • Kozlowski JM, Ellis WJ, Grayhack JT. Advanced prostatic carcinoma. Early versus late endocrine therapy. Urol Clin North Am 1991;18:15-24.
    • (1991) Urol Clin North Am , vol.18 , pp. 15-24
    • Kozlowski, J.M.1    Ellis, W.J.2    Grayhack, J.T.3
  • 20
    • 0035887153 scopus 로고    scopus 로고
    • A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy
    • DeWeese TL, van der Poel H, Li S, et al. A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy. Cancer Res 2001;61:7464-72.
    • (2001) Cancer Res , vol.61 , pp. 7464-7472
    • DeWeese, T.L.1    Van Der Poel, H.2    Li, S.3
  • 21
    • 10744227813 scopus 로고    scopus 로고
    • Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate-to high-risk prostate cancer
    • Freytag SO, Stricker H, Pegg J, et al. Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate-to high-risk prostate cancer. Cancer Res 2003;63:7497-506.
    • (2003) Cancer Res , vol.63 , pp. 7497-7506
    • Freytag, S.O.1    Stricker, H.2    Pegg, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.